Accessibility Page Navigation
Style sheets must be enabled to view this page as it was intended.
The Royal College of Psychiatrists Improving the lives of people with mental illness

Schizophrenia: The NICE Guideline on Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (Updated edition)

National Collaborating Centre for Mental Health (NCCMH)


Price: £35.00

College members' price: £31.50

Published: Apr 2010

Format: Paperback + free CD-ROM

Number of pages: 498

ISBN: 9781854334794

Schizophrenia: The NICE Guideline on Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (Updated edition)

This guideline on Schizophrenia, commissioned by NICE and developed by the National Collaborating Centre for Mental Health, sets out clear, evidence- and consensus-based recommendations for healthcare staff on how to manage and treat schizophrenia in adults.

This guideline is an update of the previous guidance (full guideline published 2003), which was the first guideline that NICE ever produced and which was judged to be superior to other schizophrenia guidelines in an international survey.

This updated guideline provides new clinical and economic evidence about the use of psychological and psychosocial interventions and antipsychotic drugs and new reviews of early intervention services, primary care and treatment for physical health problems. There are also new chapters on access and engagement for minority ethnic groups and on service user and carer experience of treatment and care for schizophrenia.

List of the other NICE mental health guidelines


"The original NICE schizophrenia guideline was of remarkable superiority in its methodological quality compared with other national treatment guidelines throughout the world. This updated version of the guideline is yet again of exceptional quality, demonstrating rigour in its development, clarity in its presentation and noticeable breadth in its coverage. Whether dealing with drug and psychosocial treatments, patient experience, ethnic minorities or health economics, based on current evidence the guideline opens up new vistas on the best treatments available for people with schizophrenia. A landmark of schizophrenia practice guidelines."

- Professor Wolfgang Gaebel, Professor of Psychiatry, Department of Psychiatry and Psychotherapy of the Heinrich-Heine-University, Düsseldorf and Past President German Psychiatric Association (DGPPN)

   

 

“There are still many inequalities that exist in mental health, some of which are particularly pertinent for people with schizophrenia. These inequalities are even more difficult to overcome for people from ethnic minorities, who often gain access to help at a very late stage. This guideline is the first to tackle these problematic issues by undertaking a full evidence review of the problems faced by people from African Caribbean groups in accessing UK services. I can thoroughly recommend this world class guideline to anyone with an interest in the evidence about what works for people with schizophrenia".

- Professor Dinesh Bhugra, President, Royal College of Psychiatrists (2008-2011)

  

 

 


Correction

Unfortunately one appendix that was supposed to be included on the free data CD-ROM that accompanies Schizophrenia (Updated edn), was missed out. It can however be downloaded for free below:
Appendix 15d: Service-level interventions study characteristics tables


NICE Mental Health Guidelines

These guidelines from NICE set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions.

The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches.

The accompanying free CD-ROM contains all the data used as evidence, including:

  • Included and excluded studies.
  • Profile tables that summarise both the quality of the evidence and the results of the evidence synthesis.
  • All meta-analytical data, presented as forest plots.
  • Detailed information about how to use and interpret forest plots.

Full Contents

1. PREFACE

1.1       National guideline
1.2       The national schizophrenia guideline


2. SCHIZOPHRENIA

2.1       The disorder

2.2       Incidence and prevalence

2.3       Possible causes of schizophrenia

2.4       Assessment

2.5       Engagement, consent and therapeutic alliance

2.6       Language and stigma

2.7       Issues for families and carers

2.8       Treatment and management of schizophrenia in the NHS

2.9       The economic cost of schizophrenia

 

3. METHODS USED TO UPDATE THIS GUIDELINE

3.1       Overview

3.2       The scope

3.3       The guideline development group

3.4       Clinical questions

3.5       Systematic clinical literature review

3.6       Health economics methods

3.7       Stakeholder contributions

3.8       Validation of the guideline

 

4. EXPERIENCE OF CARE

4.1       Introduction

4.2       Methodology

4.3       Personal accounts from people with schizophrenia

4.4       Personal accounts from carers

4.5       Summary of themes from service users’ and carers’ experiences

4.6       Recommendations

 

5. ACCESS AND ENGAGEMENT

5.1       Introduction

5.2       Early intervention

5.3       Access and engagement to service-level interventions

 

6. PHARMACOLOGICAL INTERVENTIONS IN THE TREATMENT AND MANAGEMENT OF SCHIZOPHRENIA

6.1       Introduction

6.2       Initial treatment with antipsychotic medication

6.3       Oral antipsychotics in the treatment of the acute episode

6.4       Promoting recovery in people with schizophrenia that is in remission – pharmacological relapse prevention

6.5       Promoting recovery in people with schizophrenia whose illness has not responded adequately to treatment

6.6       Treatment with depot/long-acting injectable antipsychotic medication

6.7       Side effects of antipsychotic medication

6.8       Effectiveness of antipsychotic medication

6.9       Health economics

6.10     From evidence to recommendations

6.11     Recommendations

 

7. ECONOMIC MODEL – COST EFFECTIVENESS OF PHARMACOLOGICAL INTERVENTIONS FOR PEOPLE WITH SCHIZOPHRENIA

7.1       Introduction

7.2       Economic modelling methods

7.3       Results

7.4       Discussion of findings – limitations of the analysis

7.5       Conclusions

 

8. PSYCHOLOGICAL THERAPY AND PSYCHOSOCIAL INTERVENTIONS IN THE TREATMENT AND MANAGEMENT OF SCHIZOPHRENIA

8.1       Introduction

8.2       Adherence therapy

8.3       Arts therapies

8.4       Cognitive behavioural therapy

8.5       Cognitive remediation

8.6       Counselling and supportive therapy

8.7       Family intervention

8.8       Psychodynamic and psychoanalytic therapies

8.9       Psychoeducation

8.10     Social skills training

8.11     Recommendations (Across all treatments)

 

9. SERVICE-LEVEL INTERVENTIONS IN THE TREATMENT AND MANAGEMENT OF SCHIZOPHRENIA

9.1       Introduction

9.2       Interface between primary and secondary care

9.3       Community mental health teams

9.4       Assertive outreach (Assertive community treatment)

9.5       Acute day hospital care

9.6       Vocational rehabilitation

9.7       Non-acute day hospital care

9.8       Crisis resolution and home treatment teams

9.9       Intensive case management

 

10. SUMMARY OF RECOMMENDATIONS

10.1     Care across all phases

10.2     Initiation of treatment (First episode)

10.3     Treatment of the acute episode

10.4     Promoting recovery

10.5     Research recommendations

 

11. APPENDICES

12. REFERENCES

13. ABBREVIATIONS

Login
Make a Donation